Home Business Med-X, Inc.’s Cannabis Equity CrowdFunding Campaign Goes Live

Med-X, Inc.’s Cannabis Equity CrowdFunding Campaign Goes Live


At 4:20 pm Tuesday, February 9th, Med-X, Inc. released an announcement that they had officially began accepting investments for their Regulation A+ offering from excited investors, many of which are making their very first investment. This type of offering is the first of its kind for the medical cannabis industry. All of this is coming on the heels of lots of positive industry news including the ArcView 2015 report that projected the legal cannabis industry to generate 6.7 billion dollars in 2016.

From a securities standpoint, the Med-X, Inc. offering is very unique. The management team has made it possible for all investors to get in on the ground floor of a medical cannabis company positioning itself as a leader in the business. Equity Crowdfunding via Regulation A+, made possible by the JOBS Act in 2012 allows companies, qualified by the SEC, to offer shares to the general public who traditionally would not be allowed to participate in this type of investment.

“Virtually any American who earns an annual income of $4,200 and is age 18 or older can participate. “ said Matthew Mills, COO of Med-X.

In approximately an 8-week period Med-X was able to receive $3.6 million in reservations from over 1100 prospective investors for their Reg A+ campaign on StartEngine.com. With the live offering now available, interested investors can invest a minimum of $420 and receive 700 shares. Hundreds of investors have already participated.

“We have a responsibility to do our part in this industry and we could not be more proud to share this with as many people as possible. The people of this country are calling for safe, green medicine and it’s our team and these people who are going to do whatever it takes to make it happen.” said Mr. Mills.

In an interview with Mills and the team, he said the next focus for the company was to use the initial capital raised from the Crowdfunding campaign to market the Nature-Cide products, including the new Nature-Cide Professional Growing Medium to the cannabis cultivation community as well as begin the build out of the Marijuana Times Network.

“Nature-Cide has a solid foothold nationally in other sectors like hospitality and pest control. With our resources and the launch of the new soil product, we are anticipating this brand to really take off in the cultivation community, based on the initial feedback that is coming back to us.” Mills explained.

Mr. Mills will be presenting to investors and industry financial leaders on Saturday, March 5th in San Francisco at the 2016 Marijuana Investors Summit. His presentation will focus on the changes in the industry regarding pesticides as well as solutions that Med-X, Inc. has to offer.

“People want and deserve the right to know what is in their medicine. As a physician, my goal is to always to do no harm. Why would anyone want to recommend something that could be doing more harm than good?” said CEO, Dr. David Toomey.

Dr. Toomey will also be attending the 2016 Marijuana Investors Summit. It will be the first time the executives will be presenting to the investment community with the offering in a Live position. When asked what his overall feelings were to the investors response to the campaign going live, Dr. Toomey said, “We could not be in the position we are in without our team and many others who believe in this mission. We are breaking new ground and the people out there have spoken.”

Mr. Mills also shared some news on the R&D side of the business by telling us the extraction equipment is in place and several successful extractions of High CBD product have been processed. Their laboratory testing, strain development and product efficacy are in full swing running seven days a week.

“This is not our first rodeo,“ Mills explained. “Being in the green products business for years we know our products must be special and perform better than anyone else’s. Efficacy is the key and our laboratory studies are proving that every day.”

As cannabis entrepreneurs continue to push the industry forward and investments are offered to more and more people, it’s important for prospecting investors to do their due diligence, in any and all investment decisions. “Like I tell any and all investors, there is no such thing as a sure thing in the world of investing, but I would like to believe after everything our experienced management team has worked for and represents coupled with a low burn rate and a small minimum investment of $420, that we have something that everyone can believe in,” states Mills.

Go to StartEngine.com for more details.

SEC Disclaimer: The securities offered hereby are highly speculative. Investing in shares of Med-X, Inc. involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand could be illiquid for an indefinite period of time. No public market currently exists for the securities and if a public market develops following this offering it may not continue.

Forward-Looking Statements: This story may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as “expected”, “anticipated”, “projected”, and “forecasted.” Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events. Please review the offering circular link: Offering Circular